This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Areva Nc. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations in Thorium Production by Anne Montaletang
Introduction
Anne Montaletang is a notable inventor based in Rilhac Rancon, France. She has made significant contributions to the field of nuclear medicine through her innovative processes. Her work focuses on the production of thorium 228, which has important applications in the manufacture of radiopharmaceutical products.
Latest Patents
Anne Montaletang holds a patent for the "Production of thorium 228 starting from a natural thorium salt." This invention outlines a process that involves several steps, including the separation of radium from other radioelements present in natural thorium salt. The process includes coprecipitation of radium by barium sulfate, followed by the extraction of thorium 228 from the coprecipitate. The extracted thorium can then be purified and concentrated for use in various applications.
Career Highlights
Anne Montaletang is associated with Areva NC, a company that specializes in nuclear energy and related technologies. Her work has been instrumental in advancing methods for producing thorium, which is crucial for developing radiopharmaceuticals used in nuclear medicine, particularly in radioimmunotherapy for treating cancers and AIDS.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including Gilbert Andreoletti and Michel Belieres. These collaborations have contributed to the advancement of her research and the successful development of her patented processes.
Conclusion
Anne Montaletang's innovative work in the production of thorium 228 showcases her significant contributions to nuclear medicine. Her patent and collaborations highlight the importance of her research in developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
